Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)

Market Cap	4.74B
Revenue (ttm)	3.61B +70.5%
Net Income	144.76M +14.8%
EPS	1.18 +0.7%
Shares Out	143.50M
PE Ratio	28.01
Forward PE	n/a
Dividend	0.35 (1.04%)
Ex-Dividend Date	Jun 8, 2026

Volume	2,737,335
Open	33.64
Previous Close	33.73
Day's Range	32.66 - 33.97
52-Week Range	29.60 - 76.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About SHA:603334

Suzhou Fengbei Biotech Stock Co., Ltd. manufactures and sells resource-based products from utilization of waste resources in China. It offers bio-based materials for use in pesticides, fertilizers, mineral processing, ink resins, textiles, biopharmaceuticals, and other fields; biofuels; and oleochemicals, such as DD oil, fatty acids. The company was incorporated in 2014 and is based in Zhangjiagang, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 395
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603334

Financial Performance

In 2025, SHA:603334's revenue was 3.17 billion, an increase of 62.77% compared to the previous year's 1.95 billion. Earnings were 140.55 million, an increase of 13.52%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 4, 2026

Data Sources Report a data error